Avapro and Omacor drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Avapro (irbesartan) and Omacor (omega-3acid ethyl esters). Common drug interactions include chronic kidney disease among females and atrial fibrillation among males.

The phase IV clinical study analyzes what interactions people have when they take Avapro and Omacor. It is created by eHealthMe based on reports of 22 people who take the same drugs from the FDA, and is updated regularly.

What is Avapro?

Avapro has active ingredients of irbesartan. It is often used in high blood pressure. eHealthMe is studying from 19,840 Avapro users. Check the latest studies of Avapro.

What is Omacor?

Omacor has active ingredients of omega-3acid ethyl esters. It is often used in high blood cholesterol. eHealthMe is studying from 2,547 Omacor users. Check the latest studies of Omacor.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 24, 2026

22 people who take Avapro and Omacor together, and have interactions are studied.

What are the common drug interactions of Avapro and Omacor, by gender? *:

female:

Chronic kidney disease
Renal injury (kidney injury)
Alopecia (absence of hair from areas of the body)
Blood glucose increased
Diarrhoea
Ill-defined disorder
Pain

male:

Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Arthritis (form of joint disorder that involves inflammation of one or more joints)
Surgery
Thyroid disorder (thyroid diseases)
Cardiac failure congestive
Lung infection
Pneumonia
Blood potassium decreased
Dehydration (dryness resulting from the removal of water)
Drug ineffective

What are the common drug interactions of Avapro and Omacor, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Blood potassium decreased
Dehydration (dryness resulting from the removal of water)
Blood sodium decreased
Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)

60+:

Chronic kidney disease
Renal injury (kidney injury)
Alopecia (absence of hair from areas of the body)
Blood glucose increased
Diarrhoea
Hypogeusia (reduced ability to taste things (to taste sweet, sour, bitter, or salty substances))
Oral neoplasm (oral tumour)
Pain
Renal neoplasm (kidney tumour)
Weight increased

What are the existing conditions these people have? *

Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 9 people, 40.91%
Quit Smoking: 3 people, 13.64%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 9.09%
Breast Cancer: 2 people, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Avapro and Omacor?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously